UroGen Pharma (NASDAQ: URGN) director exercises 2,000 RSUs, holds 8,000 shares
Rhea-AI Filing Summary
UroGen Pharma Ltd. (URGN) director James A. Robinson Jr. reported the exercise and settlement of equity awards. On 2026-08-26, he exercised 2,000 Restricted Stock Units, each representing a contingent right to receive one ordinary share, which converted into 2,000 ordinary shares of UroGen.
The derivative RSU position of 2,000 units was fully settled, leaving no RSUs from this award outstanding, and Mr. Robinson’s directly held ordinary shares increased to 8,000 shares following the transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 2,000 shares
Net Buy
2 txns
Insider
Robinson James A. Jr.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit F1 | 2,000 | $0.00 | $0.00 |
| Exercise | ordinary shares F1 | 2,000 | -- | -- |
Holdings After Transaction:
Restricted Stock Unit — 0 shares (Direct);
ordinary shares — 8,000 shares (Direct)
Footnotes (1)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer
Key Figures
RSUs exercised: 2,000 units
Ordinary shares acquired: 2,000 shares
Ordinary shares held after transaction: 8,000 shares
+2 more
5 metrics
RSUs exercised
2,000 units
Restricted Stock Units exercised and converted on 2026-08-26
Ordinary shares acquired
2,000 shares
Ordinary shares received upon RSU exercise on 2026-08-26
Ordinary shares held after transaction
8,000 shares
Directly held by James A. Robinson Jr. following the 2026-08-26 transactions
Derivative exercises in filing
1 transaction
Exercise or conversion of derivative security reported in transactionSummary
Derivative shares exercised
2,000 shares
ExerciseShares in transactionSummary for derivative security exercises
Key Terms
Restricted Stock Unit, derivative security, ordinary shares
3 terms
Restricted Stock Unit financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
derivative security financial
"transaction_action": "derivative exercise/conversion" and transaction_type": "derivative""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
What insider transaction did URGN director James A. Robinson Jr. report?
He reported exercising 2,000 Restricted Stock Units on 2026-08-26, which converted into 2,000 ordinary shares of UroGen Pharma Ltd., increasing his directly held ordinary share position to 8,000 shares after the transaction.
How many UroGen Pharma (URGN) RSUs did James A. Robinson Jr. settle?
He settled 2,000 Restricted Stock Units. Each RSU represented a contingent right to receive one ordinary share of UroGen Pharma Ltd., resulting in the issuance of 2,000 ordinary shares upon exercise on 2026-08-26.
What does each URGN Restricted Stock Unit represent in this Form 4?
Each Restricted Stock Unit (RSU) represents a contingent right to receive one ordinary share of UroGen Pharma Ltd., as described in the footnote attached to the RSU transaction in the Form 4.
AI-generated analysis. How Rhea-AI works. Not financial advice.
